WSCD CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. WSCD Gen Silencer sind erhältlich als WSCD CRISPR/Cas9 Knockout Plasmide und WSCD Double Nickase Plasmide. WSCD CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
WSCD CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
WSCD1 CRISPR/Cas9 KO Plasmid (h) | sc-411708 | h | Gene Knockout | GFP | 0 | ||
WSCD1 HDR Plasmid (h) | sc-411708-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
WSCD1 Double Nickase Plasmid (h) | sc-411708-NIC | h | Gene Knockout | Puromycin | 0 | ||
WSCD1 Double Nickase Plasmid (h2) | sc-411708-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
WSCD1 CRISPR/Cas9 KO Plasmid (m) | sc-432144 | m | Gene Knockout | GFP | 0 | ||
WSCD1 HDR Plasmid (m) | sc-432144-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
WSCD1 Double Nickase Plasmid (m) | sc-432144-NIC | m | Gene Knockout | Puromycin | 0 | ||
WSCD1 Double Nickase Plasmid (m2) | sc-432144-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
WSCD2 CRISPR/Cas9 KO Plasmid (h) | sc-411311 | h | Gene Knockout | GFP | 0 | ||
WSCD2 HDR Plasmid (h) | sc-411311-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
WSCD2 Double Nickase Plasmid (h) | sc-411311-NIC | h | Gene Knockout | Puromycin | 0 | ||
WSCD2 Double Nickase Plasmid (h2) | sc-411311-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
WSCD2 CRISPR/Cas9 KO Plasmid (m) | sc-435839 | m | Gene Knockout | GFP | 0 | ||
WSCD2 HDR Plasmid (m) | sc-435839-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
WSCD2 Double Nickase Plasmid (m) | sc-435839-NIC | m | Gene Knockout | Puromycin | 0 | ||
WSCD2 Double Nickase Plasmid (m2) | sc-435839-NIC-2 | m | Gene Knockout | Puromycin | 0 |
WSCD CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
WSCD1 CRISPR Activation Plasmid (h) | sc-411708-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
WSCD1 CRISPR Activation Plasmid (h2) | sc-411708-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
WSCD1 Lentiviral Activation Particles (h) | sc-411708-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
WSCD1 Lentiviral Activation Particles (h2) | sc-411708-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
WSCD1 CRISPR Activation Plasmid (m) | sc-432144-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
WSCD1 CRISPR Activation Plasmid (m2) | sc-432144-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
WSCD1 Lentiviral Activation Particles (m) | sc-432144-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
WSCD1 Lentiviral Activation Particles (m2) | sc-432144-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
WSCD2 CRISPR Activation Plasmid (h) | sc-411311-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
WSCD2 CRISPR Activation Plasmid (h2) | sc-411311-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
WSCD2 Lentiviral Activation Particles (h) | sc-411311-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
WSCD2 Lentiviral Activation Particles (h2) | sc-411311-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
WSCD2 CRISPR Activation Plasmid (m) | sc-435839-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
WSCD2 CRISPR Activation Plasmid (m2) | sc-435839-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
WSCD2 Lentiviral Activation Particles (m) | sc-435839-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
WSCD2 Lentiviral Activation Particles (m2) | sc-435839-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |